[1] |
LI Can, LIU Lehuan, CHEN Xia, QU Jianbo.
Pharmacy of Chinese Medicine Compound Preparations Based on Human Experiences
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 564-569.
|
[2] |
YANG Shengxi, XU Juntong, TU Wenlian.
Research Progress in the Treatment of Advanced Non-Small Cell Lung Cancer with Aumonertinib
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 235-240.
|
[3] |
JIANG Haiyan, ZHOU Tianyu, FAN Xiaoyu, LI Wanfang, BAO Jie, JIN Hongtao.
Challenges to the current development of fixed-dose antitumor drug combinations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 961-966.
|
[4] |
GUO Shushu, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, MA Enlong, JIN Hongtao.
Rationality of compound drug components against hypertension
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 973-977.
|
[5] |
SUN Siman, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, WANG Chuan, JIN Hongtao.
Research progress in anti-AIDS compound preparations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 978-984.
|
[6] |
SHEN Xue, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, HE Bosai, JIN Hongtao.
Developments in research on combination drugs for hepatic fibrosis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 985-990.
|
[7] |
LU De, XU Wenyan, LIU Jinxin, PEI Yusheng.
Discussion and analysis of bacterial endotoxin problems in FDA warning letters
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 857-862.
|
[8] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
[9] |
LI Hongchang, GE Yunxuan, WANG Ningning, ZHOU Wei, WANG Yuguang, MA Zengchun, GAO Yue.
Research progress in roles of ginseng combined with Radix Aconiti Carmichaeli in reducing toxicity and increasing efficiency in myocardial cells
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 601-605.
|
[10] |
CHEN Liye, ZHU Li, GONG Leilei.
Pharmaceutical care of a patient with type 2 diabetes mellitus treated with a combination of traditional Chinese and Western medicine during acute exacerbation of gout
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 451-453.
|
[11] |
LIU Saiyue, LYU Xiaoqin, ZHOU Yun.
Key points of investigation and report of suspected death of adverse drug reaction
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 971-974.
|
[12] |
YAN Yishu, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Emodin -8-O-β-D-glucoside combined with paclitaxel inhibits the viability and metastasis of human breast cancer cells
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 728-734.
|
[13] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[14] |
WANG Shuwei, YIN Jinjun, WANG Bing, SONG Caiping, YANG Fujun.
Axitinib tablets combined with toripalimab injection in the treatment of renal cancer-induced central retinal artery occlusion: a case report
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 825-828.
|
[15] |
LI Rongrong, LI Meng, GOU Yue, LUO Qiong, LYU Hua, SUN Xin, LIU Chenghai.
Clinical characteristics and risk factors of 113 cases of anti-neoplastic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 505-510.
|